Search Results - zihai+li

1 Results Sort By:
Blocking GARP (LRRC32) cleavage and Its Application in Immunotherapy
Technology: Researchers at MUSC have developed a method and peptide composition (the “T250 peptide”) for treating cancer by inhibiting Glycoprotein-A Repetitions Predominant Protein (GARP) cleavage and thus impeding the activation of Transforming Growth Factor-Beta (TGF-β) – a growth factor that suppresses T-cell mediated anti-cancer...
Published: 9/23/2019   |   Inventor(s): Zihai Li
Keywords(s):  
Category(s): Therapeutic
© 2021. All Rights Reserved. Powered by Inteum